Please assess the completion status of the following clinical trial:

Trial Title: Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18~* hs CRP \>3mg/L and \<10 mg/L~Exclusion Criteria:~* Active infection~* Systemic Inflammatory Disease~* Currently on warfarin~* Cr \> 2.0~* Fish Allergy~* Pregnancy or unwillingness to use some form of birth control

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Active Arm:~1000 mg Lemon flavored Capsules. Three capsules every morning.
- 2 (Type: PLACEBO_COMPARATOR): Placebo Arm:~Cornstarch Capsules provided by Clinical Encapsulation services. Three capsules every morning.

Based on this trial design, predict the completion outcome and termination type (if applicable).